Examining buprenorphine compared to methadone for likelihood of overdose during pregnancy, 2014–2021
Pregnancy · 2026-05 · 2 (3)
DOI: 10.1002/pmf2.70276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pregnancy, online erschienen am 07.04.2026. Verfasst von Amy Board und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Birth Defects and Infant Disorders National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Preve…. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Objective
To examine the likelihood of experiencing an overdose among women receiving any buprenorphine (with or without naloxone) compared to women receiving methadone during pregnancy.
Methods
Data from the MATernaL and Infant clinical NetworK (MAT‐LINK), a longitudinal surveillance system of pregnant woman–child dyads using electronic health records (EHRs), were analyzed. Women from geographically diverse US clinical sites who had a diagnosis of opioid use disorder (OUD) during pregnancy, were prescribed medication for opioid use disorder (MOUD), and had a known birth outcome occurring between January 1, 2014 and August 31, 2021 were included. The Andersen–Gill Cox regression model for recurrent events with robust standard errors was used to model the effect of MOUD type by trimester on time to overdose or date of pregnancy outcome and calculate adjusted hazard ratios (aHRs).
Results
Among the 3682 pregnancies included in this analysis, 46 (1.2%) had at least one EHR‐documented overdose. None of the overdoses were fatal. In adjusted models, no differences in overdose were observed between pregnancies in which buprenorphine was prescribed or administered compared to pregnancies in which methadone was prescribed or administered (any drug overdose: aHR, 0.62; 95% CI, 0.31–1.23; opioid‐involved overdose: aHR, 0.49; 95% CI, 0.18–1.30). In a trimester‐specific sub‐analysis of pregnancies with at least two MOUD prescriptions or administrations, taking buprenorphine in the third trimester resulted in a decreased likelihood of any drug overdose (aHR, 0.43; 95% CI, 0.20–0.93) and opioid‐involved overdose (aHR, 0.32; 95% CI, 0.11–0.92) compared with methadone.
Conclusion
It is important that women with OUD are initiated on the medication that works best for them as early as possible during pregnancy and that reinforcement of the importance of MOUD occurs throughout pregnancy, paying special attention to disruptions in treatment during the third trimester that might increase risk for overdose.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Birth Defects and Infant Disorders National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention Atlanta Georgia USA.
- Division of Overdose Prevention National Center for Injury Prevention and Control, Centers for Disease Control and Prevention Atlanta Georgia USA.
- Epidemic Intelligence Service, Centers for Disease Control and Prevention Atlanta Georgia USA.
- Friends Research Institute Baltimore Maryland USA.
- Department of Family and Community Medicine University of New Mexico Health Sciences Center Albuquerque New Mexico USA.
- University of Utah Health Salt Lake City Utah USA.
ORCID-Profile: Kara M Rood
Förderung
- Centers for Disease Control and Prevention
Zitieren
APA
Board, A., Vivolo-Kantor, A. M., Kim, S. Y., Thomas, S. A., Tran, E. L., Terplan, M., Sanjuan, P. M., Smid, M. C., Wright, T., Seligman, N. S., Schneider, P. D., Davidson, A., Henninger, M. L., Wachman, E. M., Rood, K. M., Garcia Saavedra, L., Louis, J., Morse, D., Shakib, J., …, & Miele, K. (2026). Examining buprenorphine compared to methadone for likelihood of overdose during pregnancy, 2014–2021. Pregnancy, 2(3). https://doi.org/10.1002/pmf2.70276
Vancouver
Board A, Vivolo-Kantor AM, Kim SY, Thomas SA, Tran EL, Terplan M, et al. Examining buprenorphine compared to methadone for likelihood of overdose during pregnancy, 2014–2021. Pregnancy. 2026;2(3). doi:10.1002/pmf2.70276
BibTeX
@article{Board2026,
author = {Board, Amy and Vivolo-Kantor, Alana M and Kim, Shin Y and Thomas, Shawn A and Tran, Emmy L and Terplan, Mishka and Sanjuan, Pilar M and Smid, Marcela C and Wright, Tanner and Seligman, Neil S and Schneider, Patrick D and Davidson, Autumn and Henninger, Michelle L and Wachman, Elisha M and Rood, Kara M and Garcia Saavedra, Luigi and Louis, Judette and Morse, Diane and Shakib, Julie and Saia, Kelley A and Miele, Kathryn},
title = {Examining buprenorphine compared to methadone for likelihood of overdose during pregnancy, 2014–2021},
journal = {Pregnancy},
year = {2026},
volume = {2},
number = {3},
doi = {10.1002/pmf2.70276}
}
EUVIMED